GUARDANT Competitors

Stocks . Germany . 
Stock . GUARDANT HEALTH CL
5GH Stock  EUR 33.99  0.36  1.07%   
GUARDANT HEALTH CL competes with Danaher, Superior Plus, NMI Holdings, SIVERS SEMICONDUCTORS, and Talanx AG; as well as few others. The company classifies itself under Healthcare sector and is part of Diagnostics & Research industry. Analyzing GUARDANT HEALTH competition allows you to expand the diversification possibilities of your existing portfolios and to get a better perspective on locking in new positions. Investors sometimes prefer comparable analysis of GUARDANT HEALTH to its intrinsic valuation because they are able to contrast its competitors on a relative basis. Check out GUARDANT HEALTH Correlation with its peers.
For more detail on how to invest in GUARDANT Stock please use our How to Invest in GUARDANT HEALTH guide.
You can use the Comparative Equity Analysis module to analyze the advantages of investing in your portfolio's related equities across multiple sectors and thematic ideas. Please use the input box below to enter symbols for particular investments you would like to analyze. With the equity comparison module, you can estimate the relative effect of GUARDANT HEALTH competition on your existing holdings.
  
Specify up to 10 symbols:
Hype
Prediction
LowEstimatedHigh
29.8033.9938.18
Details
Intrinsic
Valuation
LowRealHigh
19.9424.1337.39
Details
Naive
Forecast
LowNextHigh
28.4432.6336.81
Details
Bollinger
Band Projection (param)
LowerMiddle BandUpper
15.9625.2834.60
Details

GUARDANT HEALTH Competition Correlation Matrix

Typically, diversification allows investors to combine positions across different asset classes to reduce overall portfolio risk. Correlation between GUARDANT HEALTH and its competitors represents the degree of relationship between the price movements of corresponding stocks. A correlation of about +1.0 implies that the price of GUARDANT and its corresponding peer move in tandem. A correlation of -1.0 means that prices move in opposite directions. A correlation of close to zero suggests that the price movements of assets are uncorrelated; in other words, the historical price movement of GUARDANT HEALTH CL does not affect the price movement of the other competitor.
Click cells to compare fundamentals   Check Volatility   Backtest Portfolio
High positive correlations   
8SP
+ 0.87
DAP
IUI1
+ 0.87
INVN
2DG
+ 0.75
8SP
NOH1
+ 0.74
INVN
2DG
+ 0.66
DAP
6NM
+ 0.65
DAP
  
High negative correlations   
IUI1
- 0.89
2DG
IUI1
- 0.86
8SP
INVN
- 0.84
2DG
IUI1
- 0.79
DAP
INVN
- 0.76
8SP
NOH1
- 0.71
2DG

Risk-Adjusted Indicators

There is a big difference between GUARDANT Stock performing well and GUARDANT HEALTH Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze GUARDANT HEALTH's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.
Mean DeviationJensen AlphaSortino RatioTreynor RatioSemi DeviationExpected ShortfallPotential UpsideValue @RiskMaximum Drawdown
DAP  1.02 (0.17) 0.00 (0.17) 0.00 
 0.00 
 1.95 
(2.58)
 6.53 
8SP  2.05 (0.14) 0.00  0.38  0.00 
 0.00 
 3.36 
(4.74)
 20.22 
6NM  1.21  0.10 (0.03)(0.21) 1.77 
(1.29)
 2.79 
(2.69)
 9.64 
2DG  4.15 (1.33) 0.00 (2.07) 0.00 
 0.00 
 7.14 
(8.57)
 52.42 
TLX  0.97  0.05 (0.06) 13.88  1.13 
(1.13)
 2.67 
(1.64)
 7.58 
2GB  1.80 (0.03)(0.04) 0.06  2.19 
(2.09)
 4.28 
(3.67)
 13.78 
TM9  2.78 (0.05) 0.00 (0.04) 0.00 
 0.00 
 5.56 
(6.43)
 36.50 
INVN  2.09  0.36  0.08 (1.50) 2.12 
(2.49)
 5.61 
(4.25)
 14.01 
IUI1  1.27  0.25  0.13  0.91  1.07 
(1.49)
 3.28 
(1.96)
 10.30 
NOH1  2.11  0.21  0.08  0.41  1.92 
(2.70)
 6.61 
(3.38)
 12.96 
All Fundamental Data

GUARDANT HEALTH Competitive Analysis

The better you understand GUARDANT HEALTH competitors, the better chance you have of utilizing it as a position in your portfolios. From an individual investor's perspective, GUARDANT HEALTH's competitive analysis can cover a whole range of metrics. Some of these will be more critical depending on who you are as an investor and how you react to market volatility. However, if you are locking your investment sandscape to a long-term horizon, comparing the fundamental indicator across GUARDANT HEALTH's competition over several years is one of the best ways to analyze its investment potential.
    
 Better Than Average     
    
 Worse Than Peers    View Performance Chart
5GH DAP 8SP 6NM 2DG TLX 2GB TM9 INVN IUI1
 1.07 
 33.99 
GUARDANT
 1.06 
 224.60 
Danaher
 1.44 
 4.10 
Superior
 3.16 
 36.80 
NMI
 20.00 
 0.18 
SIVERS
 0.31 
 79.70 
Talanx
 1.88 
 21.70 
2GB
 3.50 
 2.96 
NorAm
 3.03 
 3.74 
Identiv
 0.44 
 514.70 
INTUITIVE
Market Volatility
(90 Days Market Risk)
Not too volatile
Very steady
Out of control
Not too volatile
Out of control
Very steady
Not too volatile
Very risky
Relatively risky
Very steady
Market Performance
(90 Days Performance)
Good
Very Weak
Very Weak
Weak
Very Weak
Weak
Weak
Very Weak
OK
Good
Odds of Financial Distress
(Probability Of Bankruptcy)
About Average
Low
Quite High
Low
Quite High
Low
Low
Low
Below Average
Low
Current Valuation
(Equity Enterprise Value)
Over Valued
Fairly Valued
Under Valued
Under Valued
Over Valued
Under Valued
Over Valued
Over Valued
Over Valued
Under Valued
Buy or Sell Advice
(Average Analysts Consensus)
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Trade Advice
(90 Days Macroaxis Advice)
Strong Hold
Hold
Not Rated
Not Rated
Strong Sell
Not Rated
Strong Sell
Strong Sell
Strong Sell
Not Rated
Current Ratio
19.57
2.26
1.33
0.77
3.67
1.31
N/A
3.69
1.31
N/A
Net Asset
N/A
84.35 B
4.48 B
2.52 B
N/A
197.52 B
169.7 M
N/A
96.66 M
12.97 B
Profit Margin
-1.41
0.23
-0.0333
0.56
-0.89
0.0222
N/A
19.03
-0.0236
N/A
EBITDA
(462.23 M)
10.72 B
202.9 M
420.22 M
N/A
3.09 B
N/A
609.06 M
4.1 M
1.94 B
Operating Margin
-1.15
0.28
0.0049
0.78
N/A
0.0571
N/A
19.53
-0.0216
N/A
Current Valuation
N/A
200.66 B
2.78 B
1.85 B
N/A
14 B
427.85 M
5.37 B
149.13 M
86.49 B
Price To Book
N/A
4.37
1.76
1.09
N/A
1.35
4.52
0.99
2.37
8.3
Five Year Return
N/A
0.49
5.75
N/A
N/A
4.28
N/A
N/A
N/A
N/A
Beta
0.82
0.8
0.86
1.28
0.86
0.94
N/A
-0.26
1.55
N/A
Number Of Employees
1.37 K
79 K
28
242
130
24.06 K
N/A
5.8 K
329
N/A
Shares Outstanding
102.44 M
728.58 M
200.7 M
83.66 M
210.89 M
253.35 M
N/A
88.28 M
22.51 M
N/A
Cash Flow From Operations
(146.16 M)
8.52 B
248.7 M
313.39 M
N/A
10.05 B
N/A
469.32 M
1.23 M
1.49 B
Annual Yield
N/A
0.0044
0.0662
N/A
N/A
0.0447
0.0107
N/A
N/A
N/A
Total Debt
1.35 B
19.09 B
1.91 B
396.05 M
N/A
7.19 B
3.4 M
3.1 B
17.93 M
N/A
Return On Equity
-1.25
0.15
-0.0634
0.18
-0.18
0.11
N/A
11.03
-0.0353
N/A
Z Score
1.2
4.8
N/A
2.4
N/A
0.6
81.6
0.6
5.8
N/A
Return On Asset
-0.16
0.0652
0.0026
0.1
-0.11
0.0085
N/A
3.0
-0.0151
N/A
Book Value Per Share
1.63
66.47
5.52
19.32
0.24
32.56
N/A
41.02
3.29
N/A
Total Asset
N/A
84.35 B
4.48 B
2.52 B
N/A
197.52 B
169.7 M
N/A
96.66 M
12.97 B
Debt To Equity
1.6
0.48
163.2
19.0
0.088
31.9
N/A
85.3
51.4
N/A
Target Price
167.38
331.45
N/A
31.4
N/A
36.12
N/A
N/A
21.25
N/A
Last Dividend Paid
N/A
1.0
0.72
N/A
N/A
N/A
N/A
0.89
N/A
N/A
Shares Owned By Institutions
93.97
80.6
36.16
99.61
25.26
7.71
N/A
99.66
67.68
N/A
Market Capitalization
3.03 B
169.26 B
1.54 B
1.88 B
146.56 M
11.5 B
462.85 M
3.58 B
145.66 M
109.12 B
Price To Earning
N/A
48.79
30.24
11.65
N/A
12.92
N/A
9.37
N/A
N/A
Price To Earnings To Growth
N/A
3.27
N/A
N/A
N/A
N/A
N/A
N/A
N/A
3.27
Price To Sales
N/A
5.94
0.46
3.05
N/A
0.23
1.56
1.77
1.36
16.13
Net Income
(378.65 M)
7.21 B
(112.5 M)
292.9 M
N/A
1.01 B
N/A
384.46 M
1.62 M
1.32 B
Earnings Per Share
-3.92
9.11
-0.4
3.27
-0.082
4.24
N/A
4.34
-0.17
N/A
Shares Owned By Insiders
4.6
10.9
0.35
1.28
31.21
78.82
N/A
0.34
4.27
N/A
Revenue
430.76 M
31.47 B
3.38 B
524.46 M
N/A
43.38 B
N/A
2.02 B
103.77 M
6.22 B
Cash And Equivalents
1.79 B
7.32 B
33.45 M
86.67 M
N/A
3.85 B
N/A
1.29 B
8.93 M
N/A
Cash Per Share
17.69
10.26
0.19
1.28
N/A
15.22
N/A
14.66
0.54
N/A
Gross Profit
250.74 M
18.95 B
1.15 B
411.45 M
116.46 M
5.11 B
N/A
1.15 B
37.07 M
N/A
Day Typical Price
33.06
224.82
4.1
36.8
0.18
79.75
21.47
2.97
3.74
514.7
Accumulation Distribution
0.0821
0.02
N/A
N/A
N/A
0.0044
0.16
0.0067
N/A
N/A
Market Facilitation Index
2.79
4.55
N/A
N/A
N/A
0.35
0.14
0.02
N/A
N/A
Daily Balance Of Power
0.129
(0.53)
(9,223,372,036,855)
(9,223,372,036,855)
9.2 T
(0.71)
0.5714
5.0
9.2 T
(9,223,372,036,855)
Period Momentum Indicator
0.36
(2.40)
(0.06)
(1.20)
0.03
(0.25)
0.4
0.1
0.11
(2.30)
Rate Of Daily Change
1.01
0.99
0.99
0.97
1.2
1.0
1.02
1.03
1.03
1.0
Day Median Price
32.6
224.93
4.1
36.8
0.18
79.78
21.35
2.97
3.74
514.7
Price Action Indicator
1.58
(1.53)
(0.03)
(0.60)
0.015
(0.20)
0.55
0.04
0.055
(1.15)
Relative Strength Index
61.49
6.84
34.77
20.65
87.1
11.38
56.76
30.27
43.12
70.82
Coefficient Of Variation
754.84
(1,506)
(1,774)
2313.41
(587.10)
2355.3
6617.51
(190,738)
825.81
584.4
Mean Deviation
2.9
1.02
2.05
1.21
4.15
0.9742
1.8
2.78
2.09
1.27
Jensen Alpha
0.3908
(0.17)
(0.14)
0.0988
(1.33)
0.0454
(0.03)
(0.05)
0.3608
0.2534
Total Risk Alpha
(0.11)
(0.30)
(0.73)
(0.20)
(2.41)
(0.16)
(0.37)
(0.80)
(0.11)
0.014
Sortino Ratio
0.1445
N/A
N/A
(0.03)
N/A
(0.06)
(0.04)
N/A
0.0797
0.1336
Downside Variance
8.6
N/A
N/A
4.88
N/A
1.37
5.42
N/A
7.18
1.65
Standard Deviation
4.18
1.32
3.34
1.69
7.32
1.31
2.52
5.02
2.84
1.76
Kurtosis
3.63
0.42
10.9
2.1
17.11
1.25
2.01
7.85
0.3764
5.76
Potential Upside
8.18
1.95
3.36
2.79
7.14
2.67
4.28
5.56
5.61
3.28
Treynor Ratio
0.4276
(0.17)
0.3774
(0.21)
(2.07)
13.88
0.0564
(0.04)
(1.50)
0.9148
Maximum Drawdown
20.42
6.53
20.22
9.64
52.42
7.58
13.78
36.5
14.01
10.3
Variance
17.49
1.73
11.18
2.84
53.59
1.73
6.34
25.21
8.07
3.11
Market Risk Adjusted Performance
0.4376
(0.16)
0.3874
(0.20)
(2.06)
13.89
0.0664
(0.03)
(1.49)
0.9248
Risk Adjusted Performance
0.1094
(0.05)
(0.04)
0.0385
(0.12)
0.0366
0.0185
0.0081
0.0999
0.1365
Skewness
1.48
(0.44)
(0.64)
(0.72)
(2.49)
0.2695
0.6368
1.32
0.2735
1.66
Semi Deviation
2.48
N/A
N/A
1.77
N/A
1.13
2.19
N/A
2.12
1.07
Information Ratio
0.1013
(0.17)
(0.1)
(0.03)
(0.19)
(0.06)
(0.04)
(0.03)
0.0752
0.0972
Value At Risk
(4.90)
(2.58)
(4.74)
(2.69)
(8.57)
(1.64)
(3.67)
(6.43)
(4.25)
(1.96)
Expected Short fall
(3.48)
N/A
N/A
(1.29)
N/A
(1.13)
(2.09)
N/A
(2.49)
(1.49)
Downside Deviation
2.93
N/A
N/A
2.21
N/A
1.17
2.33
N/A
2.68
1.28
Semi Variance
6.17
N/A
N/A
3.13
N/A
1.28
4.78
N/A
4.51
1.14

GUARDANT HEALTH Competition Performance Charts

Five steps to successful analysis of GUARDANT HEALTH Competition

GUARDANT HEALTH's competitive analysis is the process of researching and evaluating its competitive landscape. It provides an understanding of the strengths, weaknesses, opportunities, and threats (SWOT) faced by GUARDANT HEALTH CL in relation to its competition. GUARDANT HEALTH's competition analysis typically involves several steps, including:
  • Identifying the key players in the market: This involves identifying the major competitors of GUARDANT HEALTH in the market, both direct and indirect, as well as new entrants and disruptive technologies.
  • Assessing the strengths and weaknesses of each competitor: This involves evaluating each competitor's strengths and weaknesses in areas such as product offerings, market share, brand recognition, financial performance, and distribution channels.
  • Understanding the competitive environment: This involves evaluating the regulatory environment, economic conditions, and other factors that may impact GUARDANT HEALTH's competitive landscape.
  • Identifying opportunities and threats: This involves using the information gathered during the analysis to identify opportunities and threats to GUARDANT HEALTH CL, and developing a strategy to address them.
  • Evaluating the competitive landscape: This involves understanding the competitive dynamics of the market, such as pricing, marketing, and distribution strategies, as well as analyzing the competitive advantage of each competitor.
Competitive analysis is an essential tool for businesses to stay ahead of the competition and can be used to inform decision-making and strategy development. By understanding the competitive landscape and staying informed about the activities of competitors, a company can make more informed decisions and improve its overall performance.

Complement your GUARDANT HEALTH position

In addition to having GUARDANT HEALTH in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Aircraft Thematic Idea Now

Aircraft
Aircraft Theme
Fama and French investing themes focus on testing asset pricing under different economic assumptions. The Aircraft theme has 45 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Aircraft Theme or any other thematic opportunities.
View All  Next Launch

Other Information on Investing in GUARDANT Stock

GUARDANT HEALTH financial ratios help investors to determine whether GUARDANT Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in GUARDANT with respect to the benefits of owning GUARDANT HEALTH security.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY